Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $60.62, moving -2.38% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.55% for ...
Zacks Investment Research on MSN
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
The University of Chicago and Morningstar, Inc. have reached an agreement for Morningstar to acquire the UChicago-affiliated Center for Research in Security Prices (CRSP), a leading source of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback